Bristol Myers Squibb announced that it has successfully completed its acquisition of Mirati Therapeutics.
Bristol Myers Squibb announced that it has successfully completed its acquisition of Mirati Therapeutics, Inc.®. With the completion of the acquisition, Mirati shares have ceased trading on the NASDAQ Global Select Market and Mirati is now a wholly owned subsidiary…